Global Compound Formula Granules Market Research Report 2025

Publication ID:

PB505257514

Publication Date:

May 30, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Compound Formula Granules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Compound Formula Granules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Compound Formula Granules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Compound Formula Granules in Hospital Pharmacy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Compound Formula Granules include China TCM, Tianjin Chase Sun Pharmaceutical Co.,Ltd, China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd., China Shineway Pharm., Purapharm Corporation Limited, Xinlvse Pharmaceutical Industry Technology Development Co., Ltd, Guangxi LiuYao Group Co., Ltd, Jilin Aodong Pharmaceutical Group Co.,Ltd., Jiangsu Kanion Pharmaceutical Co.,Ltd, Chongqing Taiji Industry (Group) Co.,Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Compound Formula Granules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compound Formula Granules.
The Compound Formula Granules market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Compound Formula Granules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compound Formula Granules companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
China TCM
Tianjin Chase Sun Pharmaceutical Co.,Ltd
China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.
China Shineway Pharm.
Purapharm Corporation Limited
Xinlvse Pharmaceutical Industry Technology Development Co., Ltd
Guangxi LiuYao Group Co., Ltd
Jilin Aodong Pharmaceutical Group Co.,Ltd.
Jiangsu Kanion Pharmaceutical Co.,Ltd
Chongqing Taiji Industry (Group) Co.,Ltd.
Shanghai Pharmaceuticals Holding Co.,Ltd.
Shijiazhuang Yiling Pharmaceutical Co.,Ltd
Tasly Holding Group
HeiLongJiang ZBD Pharmaceutical Co., Ltd
Zhejiang Jolly Pharmaceutical Co., Ltd.
Segment by Type
Premixed Packaging
Individually Packaging
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Compound Formula Granules company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Compound Formula Granules Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Premixed Packaging
1.2.3 Individually Packaging
1.3 Market by Application
1.3.1 Global Compound Formula Granules Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Compound Formula Granules Market Perspective (2020-2031)
2.2 Global Compound Formula Granules Growth Trends by Region
2.2.1 Global Compound Formula Granules Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Compound Formula Granules Historic Market Size by Region (2020-2025)
2.2.3 Compound Formula Granules Forecasted Market Size by Region (2026-2031)
2.3 Compound Formula Granules Market Dynamics
2.3.1 Compound Formula Granules Industry Trends
2.3.2 Compound Formula Granules Market Drivers
2.3.3 Compound Formula Granules Market Challenges
2.3.4 Compound Formula Granules Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Compound Formula Granules Players by Revenue
3.1.1 Global Top Compound Formula Granules Players by Revenue (2020-2025)
3.1.2 Global Compound Formula Granules Revenue Market Share by Players (2020-2025)
3.2 Global Compound Formula Granules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Compound Formula Granules Revenue
3.4 Global Compound Formula Granules Market Concentration Ratio
3.4.1 Global Compound Formula Granules Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Compound Formula Granules Revenue in 2024
3.5 Global Key Players of Compound Formula Granules Head office and Area Served
3.6 Global Key Players of Compound Formula Granules, Product and Application
3.7 Global Key Players of Compound Formula Granules, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Compound Formula Granules Breakdown Data by Type
4.1 Global Compound Formula Granules Historic Market Size by Type (2020-2025)
4.2 Global Compound Formula Granules Forecasted Market Size by Type (2026-2031)
5 Compound Formula Granules Breakdown Data by Application
5.1 Global Compound Formula Granules Historic Market Size by Application (2020-2025)
5.2 Global Compound Formula Granules Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Compound Formula Granules Market Size (2020-2031)
6.2 North America Compound Formula Granules Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Compound Formula Granules Market Size by Country (2020-2025)
6.4 North America Compound Formula Granules Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Compound Formula Granules Market Size (2020-2031)
7.2 Europe Compound Formula Granules Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Compound Formula Granules Market Size by Country (2020-2025)
7.4 Europe Compound Formula Granules Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Compound Formula Granules Market Size (2020-2031)
8.2 Asia-Pacific Compound Formula Granules Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Compound Formula Granules Market Size by Region (2020-2025)
8.4 Asia-Pacific Compound Formula Granules Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Compound Formula Granules Market Size (2020-2031)
9.2 Latin America Compound Formula Granules Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Compound Formula Granules Market Size by Country (2020-2025)
9.4 Latin America Compound Formula Granules Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Compound Formula Granules Market Size (2020-2031)
10.2 Middle East & Africa Compound Formula Granules Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Compound Formula Granules Market Size by Country (2020-2025)
10.4 Middle East & Africa Compound Formula Granules Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 China TCM
11.1.1 China TCM Company Details
11.1.2 China TCM Business Overview
11.1.3 China TCM Compound Formula Granules Introduction
11.1.4 China TCM Revenue in Compound Formula Granules Business (2020-2025)
11.1.5 China TCM Recent Development
11.2 Tianjin Chase Sun Pharmaceutical Co.,Ltd
11.2.1 Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Details
11.2.2 Tianjin Chase Sun Pharmaceutical Co.,Ltd Business Overview
11.2.3 Tianjin Chase Sun Pharmaceutical Co.,Ltd Compound Formula Granules Introduction
11.2.4 Tianjin Chase Sun Pharmaceutical Co.,Ltd Revenue in Compound Formula Granules Business (2020-2025)
11.2.5 Tianjin Chase Sun Pharmaceutical Co.,Ltd Recent Development
11.3 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.
11.3.1 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Company Details
11.3.2 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Business Overview
11.3.3 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Compound Formula Granules Introduction
11.3.4 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Revenue in Compound Formula Granules Business (2020-2025)
11.3.5 China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Recent Development
11.4 China Shineway Pharm.
11.4.1 China Shineway Pharm. Company Details
11.4.2 China Shineway Pharm. Business Overview
11.4.3 China Shineway Pharm. Compound Formula Granules Introduction
11.4.4 China Shineway Pharm. Revenue in Compound Formula Granules Business (2020-2025)
11.4.5 China Shineway Pharm. Recent Development
11.5 Purapharm Corporation Limited
11.5.1 Purapharm Corporation Limited Company Details
11.5.2 Purapharm Corporation Limited Business Overview
11.5.3 Purapharm Corporation Limited Compound Formula Granules Introduction
11.5.4 Purapharm Corporation Limited Revenue in Compound Formula Granules Business (2020-2025)
11.5.5 Purapharm Corporation Limited Recent Development
11.6 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd
11.6.1 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Company Details
11.6.2 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Business Overview
11.6.3 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Compound Formula Granules Introduction
11.6.4 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Revenue in Compound Formula Granules Business (2020-2025)
11.6.5 Xinlvse Pharmaceutical Industry Technology Development Co., Ltd Recent Development
11.7 Guangxi LiuYao Group Co., Ltd
11.7.1 Guangxi LiuYao Group Co., Ltd Company Details
11.7.2 Guangxi LiuYao Group Co., Ltd Business Overview
11.7.3 Guangxi LiuYao Group Co., Ltd Compound Formula Granules Introduction
11.7.4 Guangxi LiuYao Group Co., Ltd Revenue in Compound Formula Granules Business (2020-2025)
11.7.5 Guangxi LiuYao Group Co., Ltd Recent Development
11.8 Jilin Aodong Pharmaceutical Group Co.,Ltd.
11.8.1 Jilin Aodong Pharmaceutical Group Co.,Ltd. Company Details
11.8.2 Jilin Aodong Pharmaceutical Group Co.,Ltd. Business Overview
11.8.3 Jilin Aodong Pharmaceutical Group Co.,Ltd. Compound Formula Granules Introduction
11.8.4 Jilin Aodong Pharmaceutical Group Co.,Ltd. Revenue in Compound Formula Granules Business (2020-2025)
11.8.5 Jilin Aodong Pharmaceutical Group Co.,Ltd. Recent Development
11.9 Jiangsu Kanion Pharmaceutical Co.,Ltd
11.9.1 Jiangsu Kanion Pharmaceutical Co.,Ltd Company Details
11.9.2 Jiangsu Kanion Pharmaceutical Co.,Ltd Business Overview
11.9.3 Jiangsu Kanion Pharmaceutical Co.,Ltd Compound Formula Granules Introduction
11.9.4 Jiangsu Kanion Pharmaceutical Co.,Ltd Revenue in Compound Formula Granules Business (2020-2025)
11.9.5 Jiangsu Kanion Pharmaceutical Co.,Ltd Recent Development
11.10 Chongqing Taiji Industry (Group) Co.,Ltd.
11.10.1 Chongqing Taiji Industry (Group) Co.,Ltd. Company Details
11.10.2 Chongqing Taiji Industry (Group) Co.,Ltd. Business Overview
11.10.3 Chongqing Taiji Industry (Group) Co.,Ltd. Compound Formula Granules Introduction
11.10.4 Chongqing Taiji Industry (Group) Co.,Ltd. Revenue in Compound Formula Granules Business (2020-2025)
11.10.5 Chongqing Taiji Industry (Group) Co.,Ltd. Recent Development
11.11 Shanghai Pharmaceuticals Holding Co.,Ltd.
11.11.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Details
11.11.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Business Overview
11.11.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Compound Formula Granules Introduction
11.11.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Revenue in Compound Formula Granules Business (2020-2025)
11.11.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Development
11.12 Shijiazhuang Yiling Pharmaceutical Co.,Ltd
11.12.1 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Company Details
11.12.2 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Business Overview
11.12.3 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Compound Formula Granules Introduction
11.12.4 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Revenue in Compound Formula Granules Business (2020-2025)
11.12.5 Shijiazhuang Yiling Pharmaceutical Co.,Ltd Recent Development
11.13 Tasly Holding Group
11.13.1 Tasly Holding Group Company Details
11.13.2 Tasly Holding Group Business Overview
11.13.3 Tasly Holding Group Compound Formula Granules Introduction
11.13.4 Tasly Holding Group Revenue in Compound Formula Granules Business (2020-2025)
11.13.5 Tasly Holding Group Recent Development
11.14 HeiLongJiang ZBD Pharmaceutical Co., Ltd
11.14.1 HeiLongJiang ZBD Pharmaceutical Co., Ltd Company Details
11.14.2 HeiLongJiang ZBD Pharmaceutical Co., Ltd Business Overview
11.14.3 HeiLongJiang ZBD Pharmaceutical Co., Ltd Compound Formula Granules Introduction
11.14.4 HeiLongJiang ZBD Pharmaceutical Co., Ltd Revenue in Compound Formula Granules Business (2020-2025)
11.14.5 HeiLongJiang ZBD Pharmaceutical Co., Ltd Recent Development
11.15 Zhejiang Jolly Pharmaceutical Co., Ltd.
11.15.1 Zhejiang Jolly Pharmaceutical Co., Ltd. Company Details
11.15.2 Zhejiang Jolly Pharmaceutical Co., Ltd. Business Overview
11.15.3 Zhejiang Jolly Pharmaceutical Co., Ltd. Compound Formula Granules Introduction
11.15.4 Zhejiang Jolly Pharmaceutical Co., Ltd. Revenue in Compound Formula Granules Business (2020-2025)
11.15.5 Zhejiang Jolly Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

China TCM
Tianjin Chase Sun Pharmaceutical Co.,Ltd
China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.
China Shineway Pharm.
Purapharm Corporation Limited
Xinlvse Pharmaceutical Industry Technology Development Co., Ltd
Guangxi LiuYao Group Co., Ltd
Jilin Aodong Pharmaceutical Group Co.,Ltd.
Jiangsu Kanion Pharmaceutical Co.,Ltd
Chongqing Taiji Industry (Group) Co.,Ltd.
Shanghai Pharmaceuticals Holding Co.,Ltd.
Shijiazhuang Yiling Pharmaceutical Co.,Ltd
Tasly Holding Group
HeiLongJiang ZBD Pharmaceutical Co., Ltd
Zhejiang Jolly Pharmaceutical Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂